In this video I break down Oscar Health ($OSCR) and why, in my opinion, it’s one of the only healthcare stocks right now that could realistically double—or even triple—over the next year or two. I’m a health insurance broker, so I’m not looking at this like a random ticker. I’m watching what’s happening in the ACA/Obamacare marketplace, enrollment growth, and how Oscar is actually performing versus the older legacy carriers that are falling behind in a lot of states. I go over the big catalyst that’s driving the “controversy” around the stock: the ACA premium tax credits (subsidies) and whether Congress extends them. I explain how the stock reacts to that news cycle (including how it spiked hard on rumors), and then I get into the chart levels I’m watching—support around the $11–$12 range, major resistance around $18–$18.50, and the key top near $23. I also talk price targets, including management’s longer-term view that gets you into that $45–$50 area by 2027, and why I still see a path forward even if subsidies aren’t extended. Not financial advice—just how I’m thinking through it.